J&J INNOVATIVE MEDICINE recalls IMAAVY (nipocalimab-aahu) Injection
- Published
- 14 Oct 2026
- Units affected
- 49 vials
- Agency
- FDA
- Country
- United States
The hazard
Presence of particulate matter.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01
- Brand / company
- J&J INNOVATIVE MEDICINE
- Codes / lots
- Lot JNYJ1208; Exp. 10/30/2027
- Distribution
- OH
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.